Marimed (MRMD) Non-Current Assets (2013 - 2026)
Marimed (MRMD) reported Non-Current Assets of $140.4 million for Q1 2026, down 6.4% year-over-year from $150.0 million in Q1 2025, and down 2.01% quarter-over-quarter from $143.3 million in Q4 2025.
Marimed (MRMD) Non-Current Assets (2013 - 2026) Analysis & Trends
Marimed (MRMD) has 14 years of Non-Current Assets data on file, last reported at $140.4 million in Q1 2026.
- Non-Current Assets for Q1 2026 came in at $140.4 million, down 6.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $576.4 million (down 6.27% YoY), and the FY2025 annual result was $143.3 million, down 6.65% from the prior year.
- Non-Current Assets retreated to $140.4 million in Q1 2026 per MRMD's latest filing, from $143.3 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $156.0 million in Q3 2024 and troughed at $82.7 million in Q1 2022.
- A 5-year average of $133.9 million and a median of $143.3 million in 2025 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2022 and 2025: Non-Current Assets soared 62.13% in 2022, then declined 6.73% in 2025.
- A 5-year view of Non-Current Assets shows it stood at $108.1 million in 2022, then surged by 33.9% to $144.7 million in 2023, then rose by 6.07% to $153.5 million in 2024, then decreased by 6.65% to $143.3 million in 2025, then fell by 2.01% to $140.4 million in 2026.
- Business Quant data shows MRMD's Non-Current Assets at $140.4 million in Q1 2026, $143.3 million in Q4 2025, and $145.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 26.33 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 8.68 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 3.84 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 2.47 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 9.64 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.90 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.22 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.40 Bn |
| 10 | Marimed | - | - | 15.28 Mn | 140.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 140.40 Mn |
| Dec 31, 2025 | 143.28 Mn |
| Sep 30, 2025 | 145.51 Mn |
| Jun 30, 2025 | 147.24 Mn |
| Mar 31, 2025 | 150.00 Mn |
| Dec 31, 2024 | 153.48 Mn |
| Sep 30, 2024 | 156.00 Mn |
| Jun 30, 2024 | 155.48 Mn |
| Mar 31, 2024 | 146.44 Mn |
| Dec 31, 2023 | 144.69 Mn |
| Sep 30, 2023 | 140.03 Mn |
| Jun 30, 2023 | 131.45 Mn |
| Mar 31, 2023 | 125.02 Mn |
| Dec 31, 2022 | 108.06 Mn |
| Sep 30, 2022 | 103.82 Mn |
| Jun 30, 2022 | 102.33 Mn |
| Mar 31, 2022 | 82.67 Mn |
| Dec 31, 2021 | 78.59 Mn |
| Sep 30, 2021 | 68.45 Mn |
| Jun 30, 2021 | 63.11 Mn |